The role of endothelin II type A receptor (ETAR) in transplant injury

Terasaki, 2012, A personal perspective: 100-year history of the humoral theory of transplantation, Transplantation, 93, 751, 10.1097/TP.0b013e3182483713 Terasaki, 2005, Humoral theory of transplantation: further evidence, Curr. Opin. Immunol., 17, 541, 10.1016/j.coi.2005.07.018 Sellarés, 2012, Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence, Am. J. Transplant., 12, 388, 10.1111/j.1600-6143.2011.03840.x Tait, 2013, Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation, Transplantation, 95, 19, 10.1097/TP.0b013e31827a19cc Jordan, 2019, Immune response to non-HLA antigens and renal allograft loss, Lancet, 854, 10.1016/S0140-6736(18)33186-6 Banasik, 2014, Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss, Transplant. Proc., 46, 2618, 10.1016/j.transproceed.2014.09.029 Crespo, 2013, Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?, Transpl. Immunol., 29, 28, 10.1016/j.trim.2013.07.002 Guan, 2011, 35, 10.1159/000328720 Guan, 2015, Endothelin and the renal microcirculation, Semin. Nephrol., 35, 145, 10.1016/j.semnephrol.2015.02.004 Cha, 1992, Endothelin receptor subtypes in rat kidney epithelial cells, Jpn. J. Pharmacol., 10.1016/S0021-5198(19)49087-2 Nambi, 1992, Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands, Endocrinology, 131, 1081, 10.1210/endo.131.3.1324149 Pollock, 1998, Endothelin receptor subtypes and tissue distribution, 1 Zhou, 2018, Structural biology of G protein-coupled receptor signaling complexes, Protein Sci. Philogene, 2019, Antibodies against angiotensin II type 1 and Endothelin A receptors: relevance and pathogenicity, Hum. Immunol., 80, 561, 10.1016/j.humimm.2019.04.012 Simonson, 1993, Endothelins: multifunctional renal peptides, Physiol. Rev., 73, 375, 10.1152/physrev.1993.73.2.375 Marshall, 1999, Influence of endothelins and sarafotoxin 6c and L -NAME on renal vasoconstriction in the anaesthetized rat, Br. J. Pharmacol., 809, 10.1038/sj.bjp.0702846 Miyauchi, 2013, 1402 Bhatt, 1997, Endothelins and anti-endothelins, J. Assoc. Physicians India, 45, 868 Freischlag, 2016, The clinical impact of non-HLA antibodies in solid organ transplantation, Clin. Transpl., 32, 31 Stanhewicz, 2017, Alterations in endothelin type B receptor contribute to microvascular dysfunction in women who have had preeclampsia, Clin. Sci., 131, 2777, 10.1042/CS20171292 Becker, 2014, Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis, Am. J. Respir. Crit. Care Med., 190, 808, 10.1164/rccm.201403-0442OC Jankowich, 2020, Endothelin-1 levels and cardiovascular events, Trends Cardiovasc. Med., 30, 1, 10.1016/j.tcm.2019.01.007 Guo, 2015, Anti-endothelin receptor type A autoantibodies in systemic lupus erythematosus-associated pulmonary arterial hypertension, Arthritis Rheum., 67, 2394, 10.1002/art.39212 Klein-Weigel, 2014, G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (Buerger’s disease) and their removal by immunoadsorption, Vasa, 347, 10.1024/0301-1526/a000372 Vignon-Zellweger, 2012, Endothelin and endothelin receptors in the renal and cardiovascular systems, Life Sci., 91, 490, 10.1016/j.lfs.2012.03.026 Schildroth, 2011, Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice, Nephrol. Dial. Transplant., 26, 779, 10.1093/ndt/gfq534 Tsuprykov, 2015, Endothelin-1 overexpression improves renal function in eNOS knockout mice, Cell. Physiol. Biochem., 37, 1474, 10.1159/000438516 2011 Hocher, 2000, ETA receptor blockade induces fibrosis of the clipped kidney in two-kidney-one-clip renovascular hypertensive rats, J. Hypertens., 18, 1807, 10.1097/00004872-200018120-00015 Hocher, 2003, ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease, J. Am. Soc. Nephrol., 14, 367, 10.1097/01.ASN.0000042165.63601.65 Quaschning, 2007, Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice, J. Am. Soc. Nephrol., 730, 10.1681/ASN.2006050541 Saleh, 2010, Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat, Hypertension, 56, 942, 10.1161/HYPERTENSIONAHA.110.156570 Ortmann, 2004, Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition, Hypertension, 44, 974, 10.1161/01.HYP.0000149249.09147.b4 Li, 2016, Endothelin receptor Down-regulation mediated ligand regulation mechanisms protect against cellular hypoxia injury in rat vascular endothelial cells, Cell. Physiol. Biochem., 40, 1443, 10.1159/000453196 Forbes, 2001, Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function, Kidney Int., 59, 1333, 10.1046/j.1523-1755.2001.0590041333.x Forbes, 2001, Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure, Exp. Nephrol., 9, 309, 10.1159/000052626 Forbes, 1999, Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists, Kidney Int., 55, 198, 10.1046/j.1523-1755.1999.00253.x Li, 2019, Downregulation of endothelin A receptor (ETaR) ameliorates renal ischemia reperfusion injury by increasing nitric oxide production, Life Sci., 228, 295, 10.1016/j.lfs.2019.05.013 Yard, 1993, The clinical significance of allospecific antibodies against endothelial cells detected with an antibody-dependent cellular cytotoxicity assay for vascular rejection and graft loss after renal transplantation, Transplantation, 55, 1287, 10.1097/00007890-199306000-00015 Jackson, 2019, Sensitization to endothelial cell antigens: unraveling the cause or effect paradox, Hum. Immunol., 80, 614, 10.1016/j.humimm.2019.04.014 Kummer, 2020, Vascular signaling in allogenic solid organ transplantation – the role of endothelial cells, Front. Physiol., 11, 443, 10.3389/fphys.2020.00443 Piotti, 2014, Vascular endothelium as a target of immune response in renal transplant rejection, Front. Immunol., 5, 505, 10.3389/fimmu.2014.00505 Dragun, 2016, Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity, Kidney Int., 280, 10.1016/j.kint.2016.03.019 Banasik, 2014, The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes, Transpl. Immunol., 30, 24, 10.1016/j.trim.2013.10.007 Kaminska, 2007, Cytokine gene expression in kidney allograft biopsies after donor brain death and ischemia-reperfusion injury using in situ reverse-transcription polymerase chain reaction analysis, Transplantation, 84, 1118, 10.1097/01.tp.0000287190.86654.74 Zhang, 2016, The importance of non-HLA antibodies in transplantation, Nat. Rev. Nephrol., 12, 484, 10.1038/nrneph.2016.88 Pearl, 2020, Endothelin type a receptor antibodies are associated with angiotensin II type 1 receptor antibodies, vascular inflammation, and decline in renal function in pediatric kidney transplantation, Kidney Int. Rep., 1925, 10.1016/j.ekir.2020.09.004 Wallukat, 2017, Autoantibodies directed against the endothelin A receptor in patients with benign prostatic hyperplasia, Prostate, 77, 458, 10.1002/pros.23284 JG, 2017, Non-HLA antibodies impact on C4d staining, stellate cell activation and fibrosis in liver allografts, Transplantation., 101, 2399, 10.1097/TP.0000000000001853 Cuevas, 2016, Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies, Nephrol. Dial. Transplant., 31, 1738, 10.1093/ndt/gfw204 Reinsmoen, 2017, A 3-center study reveals new insights into the impact of non-HLA antibodies on lung transplantation outcome, Transplantation, 101, 1215, 10.1097/TP.0000000000001389 Dragun, 2009, Autoimmune mediated G-protein receptor activation in cardiovascular and renal pathologies, Thromb. Haemost., 101, 643, 10.1160/TH08-10-0710 Morozumi, 2016, Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation, Nephrology, 21, 4, 10.1111/nep.12777 Kim, 2014, Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options, Pharmacotherapy, 34, 733, 10.1002/phar.1426 Valenzuela, 2017, Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies, J. Clin. Invest., 127, 2492, 10.1172/JCI90597 Montoliu, 1979, Delayed hyperacute rejection in recipients of kidney transplants from HLA identical sibling donors, Am. J. Med., 67, 590, 10.1016/0002-9343(79)90239-0 Kalil, 1989, Humoral rejection in two HLA identical living related donor kidney transplants, Transplant. Proc., 21, 711 Ahern, 1982, Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies, Transplantation, 33, 103, 10.1097/00007890-198201000-00023 Opelz, 2005, Collaborative transplant study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies, Lancet., 365, 1570, 10.1016/S0140-6736(05)66458-6 Nowańska, 2018, Endothelin A receptors expressed in renal blood vessels of renal transplant patients are connected with acute tubular necrosis or antibody-mediated rejection, Transplant. Proc., 50, 1760, 10.1016/j.transproceed.2018.05.001 Nowańska, 2021, Endothelin A receptors expressed in glomeruli of renal transplant patients may be associated with antibody-mediated rejection, J. Clin. Med. Res., 10 Porcheray, 2010, Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses, Transplantation, 1239, 10.1097/TP.0b013e3181d72091 Fichtner, 2021, Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients, Pediatr. Nephrol., 36, 2473, 10.1007/s00467-021-04969-1 Parikh, 2019, Association of Endothelin-1 with accelerated cardiac allograft vasculopathy and late mortality following heart transplantation, J. Card. Fail., 25, 97, 10.1016/j.cardfail.2018.12.001 Hiemann, 2012, Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation, Transplantation, 94, 919, 10.1097/TP.0b013e3182692ad2 O’Leary, 2021, Non-HLA autoantibodies at 1 year negatively affect 5-year native renal function in liver transplant recipients, Transplant. Proc., 53, 1019, 10.1016/j.transproceed.2021.01.013 Gerlach, 2017, Non-HLA antibodies may accelerate immune responses after intestinal and multivisceral transplantation, Transplantation, 101, 141, 10.1097/TP.0000000000001439 Banasik, 2014, Humoral immunity in hand transplantation: anti-HLA and non-HLA response, Hum. Immunol., 75, 859, 10.1016/j.humimm.2014.06.010 Yamada, 2018, Efficacy of therapeutic plasma exchange on angiotensin II type-1 receptor antibodies on two kidney transplant recipients, J. Clin. Apher., 673, 10.1002/jca.21657 Carroll, 2016, Angiotensin II type-1 receptor antibody (AT1Rab) associated humoral rejection and the effect of peri operative plasma exchange and candesartan, Hum. Immunol., 77, 1154, 10.1016/j.humimm.2016.08.009 Horinouchi, 2013, Endothelin receptor signaling: new insight into its regulatory mechanisms, J. Pharmacol. Sci., 123, 85, 10.1254/jphs.13R02CR Simonson, 1999, Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts, Transplantation., 67, 1542, 10.1097/00007890-199906270-00007 Okada, 1998, Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts: antiproliferative effects of bosentan, a nonselective endothelin receptor antagonist, Circulation, 97, 2346, 10.1161/01.CIR.97.23.2346 Shaw, 2000, Endothelin receptor antagonist SB209670 decreases lung allograft apoptosis and improves lung graft function after prolonged ischemia, J. Cardiovasc. Pharmacol., 36, S209, 10.1097/00005344-200036051-00063 Shennib, 1998, Efficacy of administering an endothelin-receptor antagonist (SB209670) in ameliorating ischemia-reperfusion injury in lung allografts, Am. J. Respir. Crit. Care Med., 157, 1975, 10.1164/ajrccm.157.6.9709131 Palmes, 2005, Amelioration of microcirculatory damage by an endothelin A receptor antagonist in a rat model of reversible acute liver failure, J. Hepatol., 42, 350, 10.1016/j.jhep.2004.11.019 Palmes, 2003, Endothelin-A receptor antagonist reduces microcirculatory disturbances and transplant dysfunction after partial liver transplantation, Liver Transpl., 9, 929, 10.1053/jlts.2003.50191 Raina, 2012, The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists, Transplantation, 94, 885, 10.1097/TP.0b013e31825f0fbe Galiè, 2016, Eur. Heart J., 37, 67, 10.1093/eurheartj/ehv317